Clinical Trials Logo

Pain Intensity Assessment clinical trials

View clinical trials related to Pain Intensity Assessment.

Filter by:
  • None
  • Page 1

NCT ID: NCT00364546 Completed - Osteoarthritis Clinical Trials

A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain

Start date: July 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of CG5503 base Immediate Release(IR) 50 mg or 100 mg taken every 4 to 6 hours as needed over the long-term exposure of 90 days in patients who have chronic pain.